Rasmus Madsen-Ribel

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Exercise or Fasting in Individuals With Type 2 Diabetes Receiving Once-Weekly Basal Insulin Icodec.

Exercise or Fasting in Individuals With Type 2 Diabetes Receiving Once-Weekly Basal Insulin Icodec.

Journal: Diabetes, obesity & metabolism

Published: April 23, 2026

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.

Journal: Clinical and translational science

Published: July 07, 2025

Pharmacokinetic properties of once-weekly insulin icodec in Chinese individuals with type 2 diabetes.

Pharmacokinetic properties of once-weekly insulin icodec in Chinese individuals with type 2 diabetes.

Journal: Journal of diabetes investigation

Published: November 22, 2024

Pharmacological characteristics of once-weekly insulin icodec in Japanese individuals with type 1 diabetes.

Pharmacological characteristics of once-weekly insulin icodec in Japanese individuals with type 1 diabetes.

Journal: Journal of diabetes investigation

Published: October 07, 2024

Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetes.

Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetes.

Journal: Diabetes, obesity & metabolism

Published: November 28, 2023

Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 2 diabetes.

Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: March 28, 2023

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing.

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing.

Journal: BMJ open diabetes research & care

Published: March 30, 2021

FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity.

FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity.

Journal: Aging cell

Published: October 11, 2019

Epigenome- and Transcriptome-wide Changes in Muscle Stem Cells from Low Birth Weight Men.

Epigenome- and Transcriptome-wide Changes in Muscle Stem Cells from Low Birth Weight Men.

Journal: Endocrine research

Published: October 01, 2019

PPARG Pro12Ala Ala carriers exhibit greater improvements in peripheral insulin sensitivity in response to 12 weeks of aerobic exercise training.

PPARG Pro12Ala Ala carriers exhibit greater improvements in peripheral insulin sensitivity in response to 12 weeks of aerobic exercise training.

Journal: Physiological genomics

Published: May 11, 2019

TCF7L2 Expression Is Regulated by Cell Differentiation and Overfeeding in Human Adipose Tissue.

TCF7L2 Expression Is Regulated by Cell Differentiation and Overfeeding in Human Adipose Tissue.

Journal: Endocrine research

Published: February 06, 2019

Skeletal muscle enhancer interactions identify genes controlling whole-body metabolism.

Skeletal muscle enhancer interactions identify genes controlling whole-body metabolism.

Journal: Nature communications

Published: January 24, 2019

Showing 1-12 of 36

Last Updated: 09/26/2026